Rank | Gene Set | Z-score |
---|---|---|
1 | seminiferous tubule development (GO:0072520) | 9.87645884 |
2 | surfactant homeostasis (GO:0043129) | 9.67973053 |
3 | chemical homeostasis within a tissue (GO:0048875) | 7.58343709 |
4 | sperm capacitation (GO:0048240) | 6.26705603 |
5 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.62132000 |
6 | regulation of T cell tolerance induction (GO:0002664) | 5.59837805 |
7 | negative regulation of complement activation (GO:0045916) | 5.29092172 |
8 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.26813698 |
9 | cellular anion homeostasis (GO:0030002) | 5.25178397 |
10 | collecting duct development (GO:0072044) | 4.94742414 |
11 | positive regulation of p38MAPK cascade (GO:1900745) | 4.89253656 |
12 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.86316072 |
13 | negative regulation of B cell mediated immunity (GO:0002713) | 4.86316072 |
14 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.83794791 |
15 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.83794791 |
16 | cell-substrate junction assembly (GO:0007044) | 4.79244917 |
17 | facial nerve structural organization (GO:0021612) | 4.76455343 |
18 | cell adhesion mediated by integrin (GO:0033627) | 4.74568314 |
19 | negative regulation of protein activation cascade (GO:2000258) | 4.69077278 |
20 | cellular response to nitric oxide (GO:0071732) | 4.65630475 |
21 | phosphate ion homeostasis (GO:0055062) | 4.57487444 |
22 | trivalent inorganic anion homeostasis (GO:0072506) | 4.57487444 |
23 | positive regulation of tolerance induction (GO:0002645) | 4.49177761 |
24 | phospholipid scrambling (GO:0017121) | 4.17900612 |
25 | negative regulation of humoral immune response (GO:0002921) | 4.15894625 |
26 | sulfate transmembrane transport (GO:1902358) | 4.09394043 |
27 | regulation of hippo signaling (GO:0035330) | 4.07071658 |
28 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.05680109 |
29 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.01922678 |
30 | cranial nerve structural organization (GO:0021604) | 4.00676208 |
31 | regulation of tolerance induction (GO:0002643) | 3.96549827 |
32 | lung epithelium development (GO:0060428) | 3.92546181 |
33 | regulation of germinal center formation (GO:0002634) | 3.90633253 |
34 | nephron epithelium morphogenesis (GO:0072088) | 3.87343796 |
35 | nephron tubule morphogenesis (GO:0072078) | 3.87343796 |
36 | hyperosmotic salinity response (GO:0042538) | 3.86004159 |
37 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.85261371 |
38 | negative regulation of hormone metabolic process (GO:0032351) | 3.85261371 |
39 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.81561714 |
40 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.80550249 |
41 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.78968042 |
42 | single fertilization (GO:0007338) | 3.78945046 |
43 | regulation of chronic inflammatory response (GO:0002676) | 3.77100259 |
44 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.75107654 |
45 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.70956541 |
46 | renal filtration (GO:0097205) | 3.69341032 |
47 | kynurenine metabolic process (GO:0070189) | 3.68546882 |
48 | positive regulation of type 2 immune response (GO:0002830) | 3.66471148 |
49 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.65982425 |
50 | protein targeting to Golgi (GO:0000042) | 3.60735381 |
51 | regulation of memory T cell differentiation (GO:0043380) | 3.60268041 |
52 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.56324773 |
53 | cellular response to reactive nitrogen species (GO:1902170) | 3.54261131 |
54 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.53978323 |
55 | phosphate ion transport (GO:0006817) | 3.53701376 |
56 | keratinocyte proliferation (GO:0043616) | 3.51982760 |
57 | membrane raft organization (GO:0031579) | 3.51977250 |
58 | response to vitamin A (GO:0033189) | 3.51558461 |
59 | metanephric nephron tubule development (GO:0072234) | 3.50579596 |
60 | metanephric tubule development (GO:0072170) | 3.50579596 |
61 | anatomical structure arrangement (GO:0048532) | 3.48395390 |
62 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.45580507 |
63 | one-carbon compound transport (GO:0019755) | 3.40627022 |
64 | regulation of p38MAPK cascade (GO:1900744) | 3.39028549 |
65 | endocrine hormone secretion (GO:0060986) | 3.36742059 |
66 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.33739732 |
67 | heterotypic cell-cell adhesion (GO:0034113) | 3.33635790 |
68 | germinal center formation (GO:0002467) | 3.32953723 |
69 | mesodermal cell differentiation (GO:0048333) | 3.29344394 |
70 | negative regulation of B cell apoptotic process (GO:0002903) | 3.26236057 |
71 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.26091542 |
72 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.23984478 |
73 | sodium ion homeostasis (GO:0055078) | 3.22587694 |
74 | metanephric nephron epithelium development (GO:0072243) | 3.22009044 |
75 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.20493267 |
76 | regulation of type 2 immune response (GO:0002828) | 3.20128985 |
77 | sulfate transport (GO:0008272) | 3.19667525 |
78 | response to nitric oxide (GO:0071731) | 3.19562508 |
79 | regulation of complement activation (GO:0030449) | 3.17870386 |
80 | hemidesmosome assembly (GO:0031581) | 3.17409798 |
81 | negative regulation of fatty acid transport (GO:2000192) | 3.13821322 |
82 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.12583449 |
83 | glomerular filtration (GO:0003094) | 3.10283293 |
84 | transepithelial transport (GO:0070633) | 3.07872451 |
85 | negative regulation of type 2 immune response (GO:0002829) | 3.07807275 |
86 | establishment of protein localization to Golgi (GO:0072600) | 3.05524916 |
87 | multicellular organismal water homeostasis (GO:0050891) | 3.05060350 |
88 | phosphate ion transmembrane transport (GO:0035435) | 3.04342444 |
89 | lymphangiogenesis (GO:0001946) | 3.03657492 |
90 | sphingosine metabolic process (GO:0006670) | 3.01961411 |
91 | renal tubule morphogenesis (GO:0061333) | 3.01677237 |
92 | tryptophan catabolic process (GO:0006569) | 3.00467559 |
93 | indole-containing compound catabolic process (GO:0042436) | 3.00467559 |
94 | indolalkylamine catabolic process (GO:0046218) | 3.00467559 |
95 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.99211170 |
96 | lung lobe morphogenesis (GO:0060463) | 2.99006494 |
97 | peptide cross-linking (GO:0018149) | 2.98020545 |
98 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.97842530 |
99 | regulation of cardioblast differentiation (GO:0051890) | 2.96307002 |
100 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.94827203 |
101 | metanephric epithelium development (GO:0072207) | 2.93073313 |
102 | iron ion import (GO:0097286) | 2.92466993 |
103 | indolalkylamine metabolic process (GO:0006586) | 2.92045634 |
104 | regulation of protein activation cascade (GO:2000257) | 2.91691763 |
105 | negative regulation of interleukin-2 production (GO:0032703) | 2.91347953 |
106 | endodermal cell differentiation (GO:0035987) | 2.88038226 |
107 | glial cell proliferation (GO:0014009) | 2.87224437 |
108 | atrioventricular valve morphogenesis (GO:0003181) | 2.86025541 |
109 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 2.85601227 |
110 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.84244716 |
111 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.84244716 |
112 | hypotonic response (GO:0006971) | 2.84117486 |
113 | endocardial cushion development (GO:0003197) | 2.83701414 |
114 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.83685170 |
115 | respiratory gaseous exchange (GO:0007585) | 2.82244342 |
116 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.81853559 |
117 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.80960866 |
118 | renal absorption (GO:0070293) | 2.80381937 |
119 | lung vasculature development (GO:0060426) | 2.79727298 |
120 | negative regulation of protein autophosphorylation (GO:0031953) | 2.79321038 |
121 | wound healing, spreading of epidermal cells (GO:0035313) | 2.77834335 |
122 | toxin transport (GO:1901998) | 2.76082537 |
123 | pattern specification involved in kidney development (GO:0061004) | 2.75328596 |
124 | regulation of cardioblast proliferation (GO:0003264) | 2.74846854 |
125 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.74846854 |
126 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.73551437 |
127 | membrane protein proteolysis (GO:0033619) | 2.72951463 |
128 | gland morphogenesis (GO:0022612) | 2.72596504 |
129 | glycerol metabolic process (GO:0006071) | 2.71902314 |
130 | epithelial cell morphogenesis (GO:0003382) | 2.71509547 |
131 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.69439732 |
132 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.68638487 |
133 | diol metabolic process (GO:0034311) | 2.67376726 |
134 | protein localization to endosome (GO:0036010) | 2.66912100 |
135 | regulation of keratinocyte proliferation (GO:0010837) | 2.66576098 |
136 | establishment of tissue polarity (GO:0007164) | 2.66489125 |
137 | establishment of planar polarity (GO:0001736) | 2.66489125 |
138 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.65254678 |
139 | water homeostasis (GO:0030104) | 2.65227367 |
140 | tryptophan metabolic process (GO:0006568) | 2.64962835 |
141 | post-embryonic morphogenesis (GO:0009886) | 2.64607622 |
142 | peptide catabolic process (GO:0043171) | 2.64423666 |
143 | desmosome organization (GO:0002934) | 2.64010213 |
144 | lung alveolus development (GO:0048286) | 2.62474162 |
145 | extracellular matrix assembly (GO:0085029) | 2.62028967 |
146 | cellular sodium ion homeostasis (GO:0006883) | 2.61891677 |
147 | response to increased oxygen levels (GO:0036296) | 2.60206350 |
148 | response to hyperoxia (GO:0055093) | 2.60206350 |
149 | negative regulation of stress fiber assembly (GO:0051497) | 2.58787198 |
150 | neuron remodeling (GO:0016322) | 2.58112483 |
151 | developmental induction (GO:0031128) | 2.55823901 |
152 | regulation of glomerular filtration (GO:0003093) | 2.55130328 |
153 | regulation of female gonad development (GO:2000194) | 2.55068479 |
154 | protein destabilization (GO:0031648) | 2.54801726 |
155 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.53915483 |
156 | regulation of platelet aggregation (GO:0090330) | 2.53324540 |
157 | negative regulation of interleukin-10 production (GO:0032693) | 2.53060223 |
158 | cholesterol efflux (GO:0033344) | 2.52918966 |
159 | fertilization (GO:0009566) | 2.52843206 |
160 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.51674224 |
161 | endothelial cell chemotaxis (GO:0035767) | 2.51649160 |
162 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.51508926 |
163 | regulation of metalloenzyme activity (GO:0048552) | 2.51022441 |
164 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.49624505 |
165 | regulation of endothelial cell differentiation (GO:0045601) | 2.49350944 |
166 | blood vessel remodeling (GO:0001974) | 2.47736010 |
167 | smooth muscle tissue development (GO:0048745) | 2.46236999 |
168 | regulation of macrophage chemotaxis (GO:0010758) | 2.45093468 |
169 | regulation of vasculogenesis (GO:2001212) | 2.42652193 |
170 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.39758264 |
171 | lipid translocation (GO:0034204) | 2.37250467 |
172 | phospholipid translocation (GO:0045332) | 2.37250467 |
173 | extracellular matrix disassembly (GO:0022617) | 2.36803723 |
174 | cell junction assembly (GO:0034329) | 2.34706921 |
175 | positive regulation of digestive system process (GO:0060456) | 2.32697190 |
176 | cell migration involved in heart development (GO:0060973) | 2.31633343 |
177 | import into cell (GO:0098657) | 2.31377915 |
178 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.30365358 |
179 | paraxial mesoderm development (GO:0048339) | 2.29665320 |
180 | endothelial cell morphogenesis (GO:0001886) | 2.29047340 |
181 | neuromuscular junction development (GO:0007528) | 2.28625239 |
182 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.28611174 |
183 | wound healing (GO:0042060) | 2.28520131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.29816049 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.85868023 |
3 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.51389666 |
4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.35382027 |
5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.25673640 |
6 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.12938358 |
7 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.09681655 |
8 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.09681655 |
9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00658115 |
10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.00185910 |
11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.97513475 |
12 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.96824969 |
13 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.96598735 |
14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.95833360 |
15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94871451 |
16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.94320603 |
17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86972902 |
18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.83382511 |
19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81935180 |
20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80936309 |
21 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.80729647 |
22 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.73559672 |
23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71179951 |
24 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.70625171 |
25 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.64294773 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63589357 |
27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62948963 |
28 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62448425 |
29 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61186803 |
30 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.57813211 |
31 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.48639919 |
32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.48639919 |
33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48262318 |
34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.46890967 |
35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.44100263 |
36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.44082412 |
37 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43154037 |
38 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.42746019 |
39 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.42316161 |
40 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41378523 |
41 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.39883522 |
42 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39242923 |
43 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.38894365 |
44 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.37683331 |
45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37438349 |
46 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.34297640 |
47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.34275367 |
48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32590227 |
49 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32531249 |
50 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31918866 |
51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30955474 |
52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30595203 |
53 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30433315 |
54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30364748 |
55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.27966331 |
56 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.27471072 |
57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27162742 |
58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27162742 |
59 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27080644 |
60 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.26492377 |
61 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25427037 |
62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24434796 |
63 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24284881 |
64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.24260809 |
65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24038604 |
66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23717171 |
67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23697062 |
68 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.23221196 |
69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22348134 |
70 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.22336452 |
71 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22088396 |
72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21708062 |
73 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21405754 |
74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21245285 |
75 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.20874159 |
76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19750020 |
77 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19053190 |
78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18321656 |
79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18280589 |
80 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.17838704 |
81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17419778 |
82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16896070 |
83 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.16734813 |
84 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.16472540 |
85 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14840103 |
86 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14732036 |
87 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.14269459 |
88 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.14269459 |
89 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.13616610 |
90 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.13482236 |
91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11847737 |
92 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11753164 |
93 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.11406397 |
94 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.10870491 |
95 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.10746217 |
96 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10339721 |
97 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09138532 |
98 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.08823801 |
99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08415903 |
100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08276118 |
101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08238880 |
102 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07920842 |
103 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.07282045 |
104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06732478 |
105 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04847720 |
106 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04004600 |
107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03852412 |
108 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.03671107 |
109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03603116 |
110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02681481 |
111 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02318304 |
112 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.01947163 |
113 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01938699 |
114 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01513035 |
115 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01104756 |
116 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.00698094 |
117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00237398 |
118 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00039157 |
119 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99630648 |
120 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.99595647 |
121 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99067589 |
122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98872463 |
123 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98773134 |
124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98767086 |
125 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.98210807 |
126 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.97959016 |
127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97227969 |
128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.97219116 |
129 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97015162 |
130 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96725429 |
131 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.96563443 |
132 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96382765 |
133 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.96076545 |
134 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95934375 |
135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94690924 |
136 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.94345238 |
137 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94241568 |
138 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94198998 |
139 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94043035 |
140 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93994325 |
141 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93974027 |
142 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93547375 |
143 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.93138945 |
144 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92441019 |
145 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92002835 |
146 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89527521 |
147 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89269425 |
148 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89147977 |
149 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.89005082 |
150 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87253948 |
151 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81271089 |
152 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.78872193 |
153 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.75608891 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004782_abnormal_surfactant_physiolog | 6.30048015 |
2 | MP0008995_early_reproductive_senescence | 5.63384767 |
3 | MP0008004_abnormal_stomach_pH | 5.01607961 |
4 | MP0001958_emphysema | 4.08273601 |
5 | MP0000462_abnormal_digestive_system | 3.59859469 |
6 | MP0003252_abnormal_bile_duct | 3.29758214 |
7 | MP0003941_abnormal_skin_development | 2.67128321 |
8 | MP0003705_abnormal_hypodermis_morpholog | 2.66506246 |
9 | MP0005083_abnormal_biliary_tract | 2.61527403 |
10 | MP0010234_abnormal_vibrissa_follicle | 2.56516228 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.56150889 |
12 | MP0001177_atelectasis | 2.54664028 |
13 | MP0003045_fibrosis | 2.52634135 |
14 | MP0002234_abnormal_pharynx_morphology | 2.45469423 |
15 | MP0002138_abnormal_hepatobiliary_system | 2.42620972 |
16 | MP0010678_abnormal_skin_adnexa | 2.41107093 |
17 | MP0003303_peritoneal_inflammation | 2.38215429 |
18 | MP0000383_abnormal_hair_follicle | 2.29837888 |
19 | MP0010352_gastrointestinal_tract_polyps | 2.27418798 |
20 | MP0005388_respiratory_system_phenotype | 2.02298875 |
21 | MP0002133_abnormal_respiratory_system | 2.02298875 |
22 | MP0002139_abnormal_hepatobiliary_system | 2.00763858 |
23 | MP0004185_abnormal_adipocyte_glucose | 1.99090488 |
24 | MP0003191_abnormal_cellular_cholesterol | 1.91663604 |
25 | MP0009384_cardiac_valve_regurgitation | 1.90125323 |
26 | MP0003453_abnormal_keratinocyte_physiol | 1.89716713 |
27 | MP0002060_abnormal_skin_morphology | 1.89675431 |
28 | MP0000537_abnormal_urethra_morphology | 1.89097181 |
29 | MP0001188_hyperpigmentation | 1.84723669 |
30 | MP0005623_abnormal_meninges_morphology | 1.84325007 |
31 | MP0001542_abnormal_bone_strength | 1.82886061 |
32 | MP0005379_endocrine/exocrine_gland_phen | 1.82513907 |
33 | MP0005360_urolithiasis | 1.72910061 |
34 | MP0002168_other_aberrant_phenotype | 1.72831954 |
35 | MP0002249_abnormal_larynx_morphology | 1.72115011 |
36 | MP0001879_abnormal_lymphatic_vessel | 1.69795726 |
37 | MP0005409_darkened_coat_color | 1.65152422 |
38 | MP0005451_abnormal_body_composition | 1.64872704 |
39 | MP0005085_abnormal_gallbladder_physiolo | 1.57777478 |
40 | MP0005408_hypopigmentation | 1.56828989 |
41 | MP0001666_abnormal_nutrient_absorption | 1.56762073 |
42 | MP0002928_abnormal_bile_duct | 1.55022799 |
43 | MP0009780_abnormal_chondrocyte_physiolo | 1.47977152 |
44 | MP0001853_heart_inflammation | 1.45905481 |
45 | MP0010368_abnormal_lymphatic_system | 1.41886705 |
46 | MP0000566_synostosis | 1.38475571 |
47 | MP0003828_pulmonary_edema | 1.37437378 |
48 | MP0004043_abnormal_pH_regulation | 1.36191204 |
49 | MP0000613_abnormal_salivary_gland | 1.34948669 |
50 | MP0004272_abnormal_basement_membrane | 1.34648916 |
51 | MP0005164_abnormal_response_to | 1.34457343 |
52 | MP0006138_congestive_heart_failure | 1.34440039 |
53 | MP0000013_abnormal_adipose_tissue | 1.33988630 |
54 | MP0005220_abnormal_exocrine_pancreas | 1.32151711 |
55 | MP0001216_abnormal_epidermal_layer | 1.25231119 |
56 | MP0001765_abnormal_ion_homeostasis | 1.22713572 |
57 | MP0003279_aneurysm | 1.22635061 |
58 | MP0001661_extended_life_span | 1.22531928 |
59 | MP0004130_abnormal_muscle_cell | 1.20726391 |
60 | MP0010329_abnormal_lipoprotein_level | 1.19553042 |
61 | MP0003385_abnormal_body_wall | 1.19263957 |
62 | MP0005595_abnormal_vascular_smooth | 1.17995959 |
63 | MP0002295_abnormal_pulmonary_circulatio | 1.17633270 |
64 | MP0001849_ear_inflammation | 1.17180707 |
65 | MP0000767_abnormal_smooth_muscle | 1.11410833 |
66 | MP0000534_abnormal_ureter_morphology | 1.10267119 |
67 | MP0004883_abnormal_blood_vessel | 1.09244104 |
68 | MP0004264_abnormal_extraembryonic_tissu | 1.08398617 |
69 | MP0002254_reproductive_system_inflammat | 1.08140001 |
70 | MP0005395_other_phenotype | 1.08093678 |
71 | MP0000467_abnormal_esophagus_morphology | 1.07955588 |
72 | MP0005503_abnormal_tendon_morphology | 1.06670195 |
73 | MP0000377_abnormal_hair_follicle | 1.05313951 |
74 | MP0001175_abnormal_lung_morphology | 1.04693391 |
75 | MP0000003_abnormal_adipose_tissue | 1.03621358 |
76 | MP0001664_abnormal_digestion | 1.01758447 |
77 | MP0000733_abnormal_muscle_development | 0.99270846 |
78 | MP0002136_abnormal_kidney_physiology | 0.98520640 |
79 | MP0003950_abnormal_plasma_membrane | 0.98361401 |
80 | MP0008961_abnormal_basal_metabolism | 0.97154244 |
81 | MP0002098_abnormal_vibrissa_morphology | 0.96316629 |
82 | MP0000685_abnormal_immune_system | 0.95170066 |
83 | MP0001851_eye_inflammation | 0.94639402 |
84 | MP0003786_premature_aging | 0.93686978 |
85 | MP0010030_abnormal_orbit_morphology | 0.93438138 |
86 | MP0002118_abnormal_lipid_homeostasis | 0.92965436 |
87 | MP0005501_abnormal_skin_physiology | 0.92145255 |
88 | MP0003724_increased_susceptibility_to | 0.92122834 |
89 | MP0003183_abnormal_peptide_metabolism | 0.90205097 |
90 | MP0000639_abnormal_adrenal_gland | 0.90081082 |
91 | MP0002796_impaired_skin_barrier | 0.89590148 |
92 | MP0003091_abnormal_cell_migration | 0.86712681 |
93 | MP0005381_digestive/alimentary_phenotyp | 0.86118304 |
94 | MP0005365_abnormal_bile_salt | 0.85729866 |
95 | MP0003195_calcinosis | 0.85043665 |
96 | MP0005375_adipose_tissue_phenotype | 0.84674549 |
97 | MP0003718_maternal_effect | 0.84254283 |
98 | MP0006054_spinal_hemorrhage | 0.83873883 |
99 | MP0005058_abnormal_lysosome_morphology | 0.83674934 |
100 | MP0000678_abnormal_parathyroid_gland | 0.83486463 |
101 | MP0001943_abnormal_respiration | 0.83051009 |
102 | MP0002909_abnormal_adrenal_gland | 0.82424010 |
103 | MP0004145_abnormal_muscle_electrophysio | 0.82416119 |
104 | MP0005165_increased_susceptibility_to | 0.80496132 |
105 | MP0003566_abnormal_cell_adhesion | 0.79112761 |
106 | MP0000579_abnormal_nail_morphology | 0.78021874 |
107 | MP0005084_abnormal_gallbladder_morpholo | 0.77486269 |
108 | MP0002925_abnormal_cardiovascular_devel | 0.76581484 |
109 | MP0005257_abnormal_intraocular_pressure | 0.76555764 |
110 | MP0000427_abnormal_hair_cycle | 0.75602570 |
111 | MP0005666_abnormal_adipose_tissue | 0.74956582 |
112 | MP0002998_abnormal_bone_remodeling | 0.74480301 |
113 | MP0000627_abnormal_mammary_gland | 0.74470423 |
114 | MP0002877_abnormal_melanocyte_morpholog | 0.74266236 |
115 | MP0002405_respiratory_system_inflammati | 0.73843496 |
116 | * MP0005410_abnormal_fertilization | 0.72984803 |
117 | MP0002108_abnormal_muscle_morphology | 0.72019367 |
118 | MP0005166_decreased_susceptibility_to | 0.71403679 |
119 | MP0004084_abnormal_cardiac_muscle | 0.70521307 |
120 | MP0001614_abnormal_blood_vessel | 0.70189667 |
121 | MP0003300_gastrointestinal_ulcer | 0.69786837 |
122 | MP0005023_abnormal_wound_healing | 0.69591384 |
123 | MP0002332_abnormal_exercise_endurance | 0.67928272 |
124 | MP0005275_abnormal_skin_tensile | 0.67533762 |
125 | MP0009643_abnormal_urine_homeostasis | 0.67336316 |
126 | MP0004947_skin_inflammation | 0.67083517 |
127 | MP0005387_immune_system_phenotype | 0.66862391 |
128 | MP0001790_abnormal_immune_system | 0.66862391 |
129 | MP0001440_abnormal_grooming_behavior | 0.66652008 |
130 | MP0003890_abnormal_embryonic-extraembry | 0.66586306 |
131 | MP0002896_abnormal_bone_mineralization | 0.66308970 |
132 | MP0006072_abnormal_retinal_apoptosis | 0.65898685 |
133 | MP0000465_gastrointestinal_hemorrhage | 0.65794386 |
134 | MP0000762_abnormal_tongue_morphology | 0.65549054 |
135 | MP0000249_abnormal_blood_vessel | 0.64374179 |
136 | MP0003448_altered_tumor_morphology | 0.64113687 |
137 | MP0002736_abnormal_nociception_after | 0.63713287 |
138 | MP0004742_abnormal_vestibular_system | 0.63703292 |
139 | MP0003115_abnormal_respiratory_system | 0.63195259 |
140 | MP0005076_abnormal_cell_differentiation | 0.62913963 |
141 | MP0002932_abnormal_joint_morphology | 0.62323919 |
142 | MP0002128_abnormal_blood_circulation | 0.61245937 |
143 | MP0005508_abnormal_skeleton_morphology | 0.61092347 |
144 | MP0009840_abnormal_foam_cell | 0.60510842 |
145 | MP0010771_integument_phenotype | 0.60034217 |
146 | MP0009931_abnormal_skin_appearance | 0.57877825 |
147 | MP0003075_altered_response_to | 0.57781601 |
148 | MP0001243_abnormal_dermal_layer | 0.52044124 |
149 | MP0000681_abnormal_thyroid_gland | 0.51707222 |
150 | MP0005621_abnormal_cell_physiology | 0.50161508 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Interstitial pulmonary disease (HP:0006530) | 9.01272498 |
2 | Tachypnea (HP:0002789) | 5.95044702 |
3 | Tubulointerstitial fibrosis (HP:0005576) | 5.85327285 |
4 | Hyperactive renin-angiotensin system (HP:0000841) | 5.57298254 |
5 | Upper limb muscle weakness (HP:0003484) | 5.02522977 |
6 | Respiratory distress (HP:0002098) | 4.58783748 |
7 | Hyperkalemia (HP:0002153) | 4.52052371 |
8 | Cerebral aneurysm (HP:0004944) | 4.48230273 |
9 | Onycholysis (HP:0001806) | 4.43888432 |
10 | Plantar hyperkeratosis (HP:0007556) | 4.20037511 |
11 | Tubulointerstitial abnormality (HP:0001969) | 4.19009242 |
12 | Abnormality of chloride homeostasis (HP:0011422) | 4.17869655 |
13 | Neurofibrillary tangles (HP:0002185) | 4.12043093 |
14 | Chronic bronchitis (HP:0004469) | 3.96712688 |
15 | Cystic liver disease (HP:0006706) | 3.79119007 |
16 | Tubulointerstitial nephritis (HP:0001970) | 3.75208497 |
17 | Scanning speech (HP:0002168) | 3.65866801 |
18 | Popliteal pterygium (HP:0009756) | 3.65727555 |
19 | Gout (HP:0001997) | 3.62876353 |
20 | Right ventricular cardiomyopathy (HP:0011663) | 3.58705389 |
21 | Lip pit (HP:0100267) | 3.57714769 |
22 | Stomach cancer (HP:0012126) | 3.53811037 |
23 | Renal salt wasting (HP:0000127) | 3.45984684 |
24 | Abnormality of the renal cortex (HP:0011035) | 3.43826686 |
25 | Renal cortical cysts (HP:0000803) | 3.40098626 |
26 | Abnormality of the parathyroid morphology (HP:0011766) | 3.39185670 |
27 | Neonatal respiratory distress (HP:0002643) | 3.30105306 |
28 | Cerebral inclusion bodies (HP:0100314) | 3.28436918 |
29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.20915033 |
30 | Osteolytic defects of the hand bones (HP:0009699) | 3.20915033 |
31 | Thick nail (HP:0001805) | 3.16832758 |
32 | Abnormality of the fingertips (HP:0001211) | 3.15049874 |
33 | Alopecia of scalp (HP:0002293) | 3.15021932 |
34 | Glomerulosclerosis (HP:0000096) | 3.14950789 |
35 | Atrophic scars (HP:0001075) | 3.12796740 |
36 | Autoimmune thrombocytopenia (HP:0001973) | 3.05528643 |
37 | Congenital stationary night blindness (HP:0007642) | 3.01710892 |
38 | Nail dystrophy (HP:0008404) | 2.99554076 |
39 | Hyperaldosteronism (HP:0000859) | 2.92154857 |
40 | Tetany (HP:0001281) | 2.90321172 |
41 | Arterial tortuosity (HP:0005116) | 2.89141885 |
42 | Vascular tortuosity (HP:0004948) | 2.86152711 |
43 | Unilateral renal agenesis (HP:0000122) | 2.82745326 |
44 | Complement deficiency (HP:0004431) | 2.75428009 |
45 | Abnormality of nail color (HP:0100643) | 2.74339260 |
46 | Abnormality of renin-angiotensin system (HP:0000847) | 2.73275975 |
47 | Aortic aneurysm (HP:0004942) | 2.72267828 |
48 | Aortic dissection (HP:0002647) | 2.71748509 |
49 | Fragile skin (HP:0001030) | 2.71190854 |
50 | Supranuclear gaze palsy (HP:0000605) | 2.70711457 |
51 | Milia (HP:0001056) | 2.65335906 |
52 | Thyroid-stimulating hormone excess (HP:0002925) | 2.60768979 |
53 | Pterygium (HP:0001059) | 2.60212041 |
54 | Palmoplantar hyperkeratosis (HP:0000972) | 2.57400697 |
55 | Loss of speech (HP:0002371) | 2.50425327 |
56 | Facial shape deformation (HP:0011334) | 2.50246636 |
57 | Potter facies (HP:0002009) | 2.50246636 |
58 | Abnormality of the neuromuscular junction (HP:0003398) | 2.42463863 |
59 | Fatigable weakness (HP:0003473) | 2.42463863 |
60 | Abnormality of complement system (HP:0005339) | 2.42290814 |
61 | Glomerulonephritis (HP:0000099) | 2.42115496 |
62 | Palmar hyperkeratosis (HP:0010765) | 2.41604682 |
63 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.40640015 |
64 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.39830853 |
65 | Absent/shortened dynein arms (HP:0200106) | 2.39830853 |
66 | Premature rupture of membranes (HP:0001788) | 2.34790536 |
67 | Fragile nails (HP:0001808) | 2.33811516 |
68 | Stage 5 chronic kidney disease (HP:0003774) | 2.32276423 |
69 | Hyperuricemia (HP:0002149) | 2.31544825 |
70 | Increased purine levels (HP:0004368) | 2.31544825 |
71 | Nephritis (HP:0000123) | 2.31541544 |
72 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.30580480 |
73 | Abnormality of purine metabolism (HP:0004352) | 2.28463200 |
74 | Prostate neoplasm (HP:0100787) | 2.23173805 |
75 | Striae distensae (HP:0001065) | 2.23111066 |
76 | Natal tooth (HP:0000695) | 2.22914482 |
77 | Pulmonary hypertension (HP:0002092) | 2.19363262 |
78 | Embryonal renal neoplasm (HP:0011794) | 2.18989254 |
79 | Tubular atrophy (HP:0000092) | 2.18106348 |
80 | Hyperparathyroidism (HP:0000843) | 2.18067740 |
81 | Dehydration (HP:0001944) | 2.15579744 |
82 | Hypotrichosis (HP:0001006) | 2.13881338 |
83 | Embryonal neoplasm (HP:0002898) | 2.11276853 |
84 | Aneurysm (HP:0002617) | 2.09807212 |
85 | Genetic anticipation (HP:0003743) | 2.07029411 |
86 | Ridged nail (HP:0001807) | 2.06655946 |
87 | Ankyloglossia (HP:0010296) | 2.04399789 |
88 | Adrenal hypoplasia (HP:0000835) | 2.04345505 |
89 | Abnormal blistering of the skin (HP:0008066) | 2.02675530 |
90 | Subcapsular cataract (HP:0000523) | 2.02489319 |
91 | Alveolar cell carcinoma (HP:0006519) | 2.00432102 |
92 | Pili torti (HP:0003777) | 1.99413198 |
93 | Hypophosphatemic rickets (HP:0004912) | 1.99398614 |
94 | Nasolacrimal duct obstruction (HP:0000579) | 1.99031975 |
95 | Abnormality of macrophages (HP:0004311) | 1.97009605 |
96 | Aplasia cutis congenita (HP:0001057) | 1.95669337 |
97 | Camptodactyly of toe (HP:0001836) | 1.94432864 |
98 | Amniotic constriction ring (HP:0009775) | 1.90072438 |
99 | Abnormality of placental membranes (HP:0011409) | 1.90072438 |
100 | Abnormal hemoglobin (HP:0011902) | 1.89599997 |
101 | Wormian bones (HP:0002645) | 1.89219506 |
102 | Xerostomia (HP:0000217) | 1.87394793 |
103 | Sensorimotor neuropathy (HP:0007141) | 1.87185987 |
104 | Neoplasm of the adrenal cortex (HP:0100641) | 1.87115493 |
105 | Progressive muscle weakness (HP:0003323) | 1.86355199 |
106 | Aplasia of the musculature (HP:0100854) | 1.86034351 |
107 | Abnormality of the lacrimal duct (HP:0011481) | 1.85793414 |
108 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.85670390 |
109 | Shallow orbits (HP:0000586) | 1.84858409 |
110 | Hypoplastic labia majora (HP:0000059) | 1.84043820 |
111 | Systemic lupus erythematosus (HP:0002725) | 1.83787406 |
112 | Advanced eruption of teeth (HP:0006288) | 1.83333724 |
113 | Focal segmental glomerulosclerosis (HP:0000097) | 1.83138520 |
114 | Polycystic kidney dysplasia (HP:0000113) | 1.83093610 |
115 | Malnutrition (HP:0004395) | 1.82938803 |
116 | Abnormality of potassium homeostasis (HP:0011042) | 1.82257547 |
117 | Hoarse voice (HP:0001609) | 1.81875686 |
118 | Vascular calcification (HP:0004934) | 1.81196522 |
119 | Abnormality of the renal collecting system (HP:0004742) | 1.80996409 |
120 | Mitral stenosis (HP:0001718) | 1.80987916 |
121 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.78553931 |
122 | Postural instability (HP:0002172) | 1.78382116 |
123 | Pustule (HP:0200039) | 1.77685463 |
124 | Abnormality of the labia majora (HP:0012881) | 1.77133928 |
125 | Periodontitis (HP:0000704) | 1.76793974 |
126 | Chromsome breakage (HP:0040012) | 1.76405670 |
127 | Cardiovascular calcification (HP:0011915) | 1.76151140 |
128 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75900146 |
129 | Wrist flexion contracture (HP:0001239) | 1.74404037 |
130 | Abnormality of the renal medulla (HP:0100957) | 1.73653695 |
131 | Hypotension (HP:0002615) | 1.73527304 |
132 | Acne (HP:0001061) | 1.72595048 |
133 | Hypodontia (HP:0000668) | 1.72516517 |
134 | Prolonged neonatal jaundice (HP:0006579) | 1.71889957 |
135 | Abnormality of the nasolacrimal system (HP:0000614) | 1.71206453 |
136 | Lower limb amyotrophy (HP:0007210) | 1.70712499 |
137 | Rectal prolapse (HP:0002035) | 1.70596909 |
138 | Abnormality of the peritoneum (HP:0002585) | 1.69596655 |
139 | Corneal erosion (HP:0200020) | 1.68532313 |
140 | Down-sloping shoulders (HP:0200021) | 1.68503332 |
141 | Pulmonary artery stenosis (HP:0004415) | 1.67996428 |
142 | Mitral valve prolapse (HP:0001634) | 1.65655947 |
143 | Growth hormone excess (HP:0000845) | 1.65440127 |
144 | Glucose intolerance (HP:0000833) | 1.65058174 |
145 | Humeroradial synostosis (HP:0003041) | 1.62344021 |
146 | Synostosis involving the elbow (HP:0003938) | 1.62344021 |
147 | Abnormality of oral frenula (HP:0000190) | 1.60367744 |
148 | Follicular hyperkeratosis (HP:0007502) | 1.60171471 |
149 | Absent hand (HP:0004050) | 1.59744599 |
150 | Increased CSF protein (HP:0002922) | 1.58950348 |
151 | Ulnar claw (HP:0001178) | 1.58893634 |
152 | Polycythemia (HP:0001901) | 1.58603179 |
153 | True hermaphroditism (HP:0010459) | 1.58024430 |
154 | Distal lower limb muscle weakness (HP:0009053) | 1.57853011 |
155 | Abnormality of the gastric mucosa (HP:0004295) | 1.57638516 |
156 | Tibial bowing (HP:0002982) | 1.57135812 |
157 | Stenosis of the external auditory canal (HP:0000402) | 1.56955919 |
158 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.56328602 |
159 | Pulmonary fibrosis (HP:0002206) | 1.56237892 |
160 | Midline defect of the nose (HP:0004122) | 1.56067960 |
161 | Male pseudohermaphroditism (HP:0000037) | 1.54932702 |
162 | Flat acetabular roof (HP:0003180) | 1.54196883 |
163 | Short nail (HP:0001799) | 1.54136040 |
164 | Abnormality of the salivary glands (HP:0010286) | 1.53518987 |
165 | Polar cataract (HP:0010696) | 1.52029804 |
166 | Bronchiectasis (HP:0002110) | 1.50486014 |
167 | Mediastinal lymphadenopathy (HP:0100721) | 1.50362140 |
168 | Breast carcinoma (HP:0003002) | 1.49822221 |
169 | Subacute progressive viral hepatitis (HP:0006572) | 1.47574382 |
170 | Febrile seizures (HP:0002373) | 1.47315052 |
171 | Chronic hepatic failure (HP:0100626) | 1.47290713 |
172 | Hemiplegia (HP:0002301) | 1.47284019 |
173 | Absent eyebrow (HP:0002223) | 1.45055015 |
174 | Hypoplasia of dental enamel (HP:0006297) | 1.44704551 |
175 | Adrenal overactivity (HP:0002717) | 1.44670576 |
176 | Decreased circulating renin level (HP:0003351) | 1.44161582 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAOK3 | 4.60173413 |
2 | MAP3K9 | 4.07909212 |
3 | ZAK | 4.07778475 |
4 | GRK1 | 3.92765099 |
5 | LATS1 | 3.28162896 |
6 | LMTK2 | 3.22341991 |
7 | STK39 | 3.05206805 |
8 | WNK4 | 2.80999602 |
9 | MST1R | 2.29579583 |
10 | TIE1 | 2.24097745 |
11 | NTRK3 | 2.20164750 |
12 | TTK | 2.11925917 |
13 | MST4 | 2.02953198 |
14 | FRK | 1.86075787 |
15 | STK24 | 1.82627083 |
16 | ARAF | 1.80090010 |
17 | MAP3K13 | 1.73180915 |
18 | FGFR2 | 1.71287654 |
19 | PRKCH | 1.66491350 |
20 | MAP3K2 | 1.63965805 |
21 | FGFR4 | 1.60446699 |
22 | MOS | 1.51107847 |
23 | STK38L | 1.49091330 |
24 | MAPK15 | 1.39558633 |
25 | EPHB2 | 1.38592354 |
26 | MET | 1.36452434 |
27 | FGFR3 | 1.34711431 |
28 | LRRK2 | 1.33365465 |
29 | MUSK | 1.33157173 |
30 | CAMK1D | 1.31359729 |
31 | TRIB3 | 1.28137832 |
32 | CDC42BPA | 1.21705248 |
33 | RPS6KA2 | 1.20924386 |
34 | MATK | 1.18616555 |
35 | RIPK1 | 1.16561608 |
36 | TNIK | 1.16532943 |
37 | PDGFRB | 1.14505759 |
38 | TRPM7 | 1.14021053 |
39 | PRPF4B | 1.13708470 |
40 | NEK6 | 1.09984962 |
41 | FER | 1.08416201 |
42 | MAP3K7 | 1.07912619 |
43 | TAOK1 | 1.07336986 |
44 | WNK1 | 1.05472872 |
45 | EEF2K | 1.00443926 |
46 | MELK | 0.99818860 |
47 | NLK | 0.98580389 |
48 | PTK2 | 0.96672413 |
49 | JAK1 | 0.96278409 |
50 | FLT3 | 0.96224792 |
51 | ERN1 | 0.96197186 |
52 | TGFBR1 | 0.94845457 |
53 | PRKAA2 | 0.94377028 |
54 | TYRO3 | 0.93689678 |
55 | STK3 | 0.91684176 |
56 | CDK12 | 0.91429773 |
57 | TTN | 0.91402365 |
58 | DMPK | 0.87531339 |
59 | CSK | 0.85655819 |
60 | ERBB2 | 0.84539533 |
61 | MARK2 | 0.83648221 |
62 | EPHA2 | 0.81781285 |
63 | AKT3 | 0.81694268 |
64 | TXK | 0.80156651 |
65 | GSK3A | 0.80061491 |
66 | TEC | 0.77992481 |
67 | EPHB1 | 0.76466769 |
68 | STK38 | 0.74411549 |
69 | MAPKAPK3 | 0.74388953 |
70 | CDK9 | 0.73694745 |
71 | PRKCQ | 0.71901253 |
72 | PAK2 | 0.69680357 |
73 | NEK9 | 0.68600241 |
74 | NUAK1 | 0.68005583 |
75 | CHUK | 0.67649155 |
76 | LATS2 | 0.67619225 |
77 | MAP2K1 | 0.66901715 |
78 | PDPK1 | 0.66461931 |
79 | SGK3 | 0.66330834 |
80 | PRKCE | 0.65660443 |
81 | CAMK1G | 0.64769376 |
82 | OXSR1 | 0.64286815 |
83 | DAPK2 | 0.63922699 |
84 | MTOR | 0.62835933 |
85 | PRKD2 | 0.62292894 |
86 | PTK6 | 0.61404064 |
87 | EPHA3 | 0.60771156 |
88 | SIK1 | 0.60182779 |
89 | FES | 0.60082183 |
90 | ERBB4 | 0.58879559 |
91 | SGK2 | 0.56674001 |
92 | KSR2 | 0.55969404 |
93 | ILK | 0.55428452 |
94 | CASK | 0.53645214 |
95 | ABL1 | 0.52824941 |
96 | BCR | 0.52282899 |
97 | MAP2K6 | 0.50190542 |
98 | IRAK1 | 0.49381004 |
99 | PKN2 | 0.49312896 |
100 | ICK | 0.49106283 |
101 | MAP3K3 | 0.48370430 |
102 | CDK6 | 0.48295929 |
103 | PAK3 | 0.47051792 |
104 | MAP3K6 | 0.46918857 |
105 | BRSK2 | 0.45704852 |
106 | INSRR | 0.45682557 |
107 | ZAP70 | 0.44740012 |
108 | CDK3 | 0.43789854 |
109 | RET | 0.43335945 |
110 | PRKD1 | 0.43275289 |
111 | KDR | 0.42792182 |
112 | EGFR | 0.42451466 |
113 | CSNK1E | 0.41940009 |
114 | BLK | 0.41643431 |
115 | MAP3K12 | 0.41230709 |
116 | ROCK2 | 0.40250007 |
117 | ALK | 0.39032752 |
118 | MAP3K1 | 0.38593171 |
119 | IGF1R | 0.38519234 |
120 | YES1 | 0.38310844 |
121 | PAK4 | 0.38257303 |
122 | SGK1 | 0.37893568 |
123 | PIK3CA | 0.37360133 |
124 | ROCK1 | 0.37239259 |
125 | MAP3K14 | 0.37174995 |
126 | PRKACA | 0.37057214 |
127 | CLK1 | 0.35537074 |
128 | TYK2 | 0.35516772 |
129 | PRKG2 | 0.35381140 |
130 | PDGFRA | 0.34772549 |
131 | PIK3CG | 0.32792726 |
132 | MAPK7 | 0.32194397 |
133 | MAPKAPK2 | 0.31742741 |
134 | CSNK1G1 | 0.31368398 |
135 | RPS6KL1 | 0.31024211 |
136 | RPS6KC1 | 0.31024211 |
137 | RAF1 | 0.29183106 |
138 | NTRK1 | 0.28992576 |
139 | PRKCD | 0.28873973 |
140 | CAMK2G | 0.28318221 |
141 | EIF2AK2 | 0.27782753 |
142 | MYLK | 0.27621102 |
143 | TGFBR2 | 0.27061562 |
144 | MAPK11 | 0.26406350 |
145 | RPS6KA4 | 0.26373419 |
146 | STK10 | 0.26137483 |
147 | * INSR | 0.25942290 |
148 | PRKACG | 0.25449180 |
149 | SGK223 | 0.24580134 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Mineral absorption_Homo sapiens_hsa04978 | 3.41217675 |
2 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.95303102 |
3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.68284091 |
4 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.59252656 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.49858784 |
6 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.22947172 |
7 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.21480006 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.13710464 |
9 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.03811924 |
10 | Pertussis_Homo sapiens_hsa05133 | 2.00023667 |
11 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.89498077 |
12 | ABC transporters_Homo sapiens_hsa02010 | 1.88737752 |
13 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.69717952 |
14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68579514 |
15 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.68569474 |
16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.64066833 |
17 | Phagosome_Homo sapiens_hsa04145 | 1.53794371 |
18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.51962697 |
19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.51203290 |
20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.49863143 |
21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.45941902 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45539339 |
23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.42018253 |
24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40079079 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38622108 |
26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35966036 |
27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35325210 |
28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.34981832 |
29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.33881055 |
30 | Lysosome_Homo sapiens_hsa04142 | 1.33690427 |
31 | Adherens junction_Homo sapiens_hsa04520 | 1.32529886 |
32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23995418 |
33 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.22523206 |
34 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.18558372 |
35 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.16203262 |
36 | Tight junction_Homo sapiens_hsa04530 | 1.15183057 |
37 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.14095294 |
38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13144686 |
39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12681307 |
40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11560761 |
41 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.09963435 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09746750 |
43 | Taste transduction_Homo sapiens_hsa04742 | 1.09711170 |
44 | Salivary secretion_Homo sapiens_hsa04970 | 1.08387262 |
45 | Prion diseases_Homo sapiens_hsa05020 | 1.08324783 |
46 | Bile secretion_Homo sapiens_hsa04976 | 1.07848926 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06346468 |
48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05831779 |
49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04661767 |
50 | Phototransduction_Homo sapiens_hsa04744 | 1.03881552 |
51 | Malaria_Homo sapiens_hsa05144 | 1.02272343 |
52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00627861 |
53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95575627 |
54 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93355854 |
55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92387636 |
56 | Pathways in cancer_Homo sapiens_hsa05200 | 0.92274829 |
57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90994347 |
58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.86928291 |
59 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.86559361 |
60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84511867 |
61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84479698 |
62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84243919 |
63 | Focal adhesion_Homo sapiens_hsa04510 | 0.84114903 |
64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83838898 |
65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.81919594 |
66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.81142342 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79061661 |
68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78831485 |
69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78694214 |
70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75531550 |
71 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75010462 |
72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73651827 |
73 | Gap junction_Homo sapiens_hsa04540 | 0.71832420 |
74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71263152 |
75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71132336 |
76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70880287 |
77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70159859 |
78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68531209 |
79 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67720834 |
80 | Bladder cancer_Homo sapiens_hsa05219 | 0.67479786 |
81 | Platelet activation_Homo sapiens_hsa04611 | 0.67120954 |
82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66816812 |
83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66197430 |
84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65648526 |
85 | Melanogenesis_Homo sapiens_hsa04916 | 0.64076826 |
86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63383914 |
87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63138430 |
88 | Lysine degradation_Homo sapiens_hsa00310 | 0.62998599 |
89 | Endocytosis_Homo sapiens_hsa04144 | 0.62912040 |
90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62181057 |
91 | Insulin resistance_Homo sapiens_hsa04931 | 0.61351003 |
92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60621185 |
93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59620357 |
94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59343738 |
95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59279609 |
96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58513139 |
97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57967634 |
98 | Hepatitis C_Homo sapiens_hsa05160 | 0.57960903 |
99 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57376650 |
100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56687209 |
101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55446360 |
102 | Amoebiasis_Homo sapiens_hsa05146 | 0.55251667 |
103 | Influenza A_Homo sapiens_hsa05164 | 0.55128825 |
104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54564341 |
105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54102314 |
106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54083804 |
107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53598872 |
108 | Insulin secretion_Homo sapiens_hsa04911 | 0.53473593 |
109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53358700 |
110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53195927 |
111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53160881 |
112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52477871 |
113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52444080 |
114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51944033 |
115 | Asthma_Homo sapiens_hsa05310 | 0.51872840 |
116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51049553 |
117 | Long-term depression_Homo sapiens_hsa04730 | 0.50606218 |
118 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50450985 |
119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49997418 |
120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49430258 |
121 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49212664 |
122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48120935 |
123 | Prostate cancer_Homo sapiens_hsa05215 | 0.47575505 |
124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47497566 |
125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47155321 |
126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46829025 |
127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46578272 |
128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46483959 |
129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46056535 |
130 | Apoptosis_Homo sapiens_hsa04210 | 0.45631083 |
131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45366704 |
132 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.44775336 |
133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43930102 |
134 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43917366 |
135 | Axon guidance_Homo sapiens_hsa04360 | 0.43541828 |
136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43452633 |
137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41514080 |
138 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40819989 |
139 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40523361 |
140 | Renin secretion_Homo sapiens_hsa04924 | 0.39832685 |
141 | Cocaine addiction_Homo sapiens_hsa05030 | 0.38917700 |
142 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38641108 |
143 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37720672 |
144 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37531932 |
145 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37261058 |
146 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35213663 |
147 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34813940 |
148 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.34511677 |
149 | Morphine addiction_Homo sapiens_hsa05032 | 0.32909120 |
150 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32383571 |
151 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32320511 |
152 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.32158358 |
153 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.31381108 |
154 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30593537 |